These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17182986)

  • 1. The limitations of risk factors as prognostic tools.
    Ware JH
    N Engl J Med; 2006 Dec; 355(25):2615-7. PubMed ID: 17182986
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of cardiovascular death in ESRD.
    Zoccali C; Tripepi G; Mallamaci F
    Semin Nephrol; 2005 Nov; 25(6):358-62. PubMed ID: 16298255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple biomarkers for the prediction of first major cardiovascular events and death.
    Wang TJ; Gona P; Larson MG; Tofler GH; Levy D; Newton-Cheh C; Jacques PF; Rifai N; Selhub J; Robins SJ; Benjamin EJ; D'Agostino RB; Vasan RS
    N Engl J Med; 2006 Dec; 355(25):2631-9. PubMed ID: 17182988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
    Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS
    N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.
    Pedrinelli R; Dell'Omo G; Di Bello V; Pontremoli R; Mariani M
    J Hum Hypertens; 2002 Feb; 16(2):79-89. PubMed ID: 11850764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine: an emerging risk factor.
    Skarlatos SI
    Ethn Dis; 2002; 12(1):S1-38-40. PubMed ID: 11913618
    [No Abstract]   [Full Text] [Related]  

  • 8. [The Cox model: limitations and extensions].
    Quantin C; Asselain B; Moreau T
    Rev Epidemiol Sante Publique; 1990; 38(4):341-56. PubMed ID: 2287801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for prediction of cardiovascular events.
    Mints G; Shah NR
    N Engl J Med; 2007 Apr; 356(14):1473-4; author reply 1474-5. PubMed ID: 17415904
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiovascular risk assessment for informed decision making. Validity of prediction tools].
    Lenz M; Mühlhauser I
    Med Klin (Munich); 2004 Nov; 99(11):651-61. PubMed ID: 15583875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
    Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
    Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for prediction of cardiovascular events.
    Ridker PM; Cook NR
    N Engl J Med; 2007 Apr; 356(14):1472-3; author reply 1474-5. PubMed ID: 17415901
    [No Abstract]   [Full Text] [Related]  

  • 13. A single risk factor measurement predicts 35-year mortality from cardiovascular disease.
    Menotti A; Giampaoli S
    G Ital Cardiol; 1998 Dec; 28(12):1354-62. PubMed ID: 9887388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
    Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J
    N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community.
    Larsson TE; Olauson H; Hagström E; Ingelsson E; Arnlöv J; Lind L; Sundström J
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):333-9. PubMed ID: 19948843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient questionnaires and formal education as more significant prognostic markers than radiographs or laboratory tests for rheumatoid arthritis mortality--limitations of a biomedical model to predict long-term outcomes.
    Pincus T
    Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S29-36. PubMed ID: 17708743
    [No Abstract]   [Full Text] [Related]  

  • 18. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study.
    Jaffe AS; Krumholz HM; Catellier DJ; Freedland KE; Bittner V; Blumenthal JA; Calvin JE; Norman J; Sequeira R; O'Connor C; Rich MW; Sheps D; Wu C;
    Am Heart J; 2006 Jul; 152(1):126-35. PubMed ID: 16824842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment and mortality in the Cardiovascular Health Study.
    Shavelle RM; Paculdo DR; Strauss DJ; Kush SJ
    J Insur Med; 2009; 41(2):110-6. PubMed ID: 19845213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.